These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34695561)

  • 1. Current knowledge, challenges, new perspectives of the study, and treatments of Autism Spectrum Disorder.
    Lotufo Denucci B; Silva de Lima L; Ferreira Lima Mota I; Rocha Madureira Azevedo J; Germino Veras L; Montenegro Luzardo Bicca JV; de Miranda Santana B; Beserra Pinheiro G; Gonçalves Coelho G; Mortari MR
    Reprod Toxicol; 2021 Dec; 106():82-93. PubMed ID: 34695561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic Activation of the Dopaminergic Neuronal Pathway Improves Behavioral Abnormalities in the Prenatal Valproic Acid Exposure Mouse Model of Autism Spectrum Disorder].
    Hara Y
    Yakugaku Zasshi; 2019; 139(11):1391-1396. PubMed ID: 31685735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics of autism spectrum disorder.
    Brown JT; Eum S; Cook EH; Bishop JR
    Pharmacogenomics; 2017 Mar; 18(4):403-414. PubMed ID: 28244813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of oxytocin administration on individuals with ASD: Neuroimaging and behavioral evidence.
    Baker E; Stavropoulos KKM
    Prog Mol Biol Transl Sci; 2020; 173():209-238. PubMed ID: 32711811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Update on Psychopharmacological Treatment of Autism Spectrum Disorder.
    Aishworiya R; Valica T; Hagerman R; Restrepo B
    Neurotherapeutics; 2022 Jan; 19(1):248-262. PubMed ID: 35029811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The psychopharmacology of autism spectrum disorder and Rett syndrome.
    Persico AM; Ricciardello A; Cucinotta F
    Handb Clin Neurol; 2019; 165():391-414. PubMed ID: 31727226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agmatine rescues autistic behaviors in the valproic acid-induced animal model of autism.
    Kim JW; Seung H; Kim KC; Gonzales ELT; Oh HA; Yang SM; Ko MJ; Han SH; Banerjee S; Shin CY
    Neuropharmacology; 2017 Feb; 113(Pt A):71-81. PubMed ID: 27638451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxytocin administration modulates the complex type of ultrasonic vocalisation of mice pups prenatally exposed to valproic acid.
    Tsuji T; Mizutani R; Minami K; Furuhara K; Fujisaku T; Pinyue F; Jing Z; Tsuji C
    Neurosci Lett; 2021 Jul; 758():135985. PubMed ID: 34048819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autism Spectrum Disorder: Classification, diagnosis and therapy.
    Sharma SR; Gonda X; Tarazi FI
    Pharmacol Ther; 2018 Oct; 190():91-104. PubMed ID: 29763648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding autism spectrum disorders with animal models: applications, insights, and perspectives.
    Li Z; Zhu YX; Gu LJ; Cheng Y
    Zool Res; 2021 Nov; 42(6):800-824. PubMed ID: 34755500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Larval zebrafish model for studying the effects of valproic acid on neurodevelopment: An approach towards modeling autism.
    Dwivedi S; Medishetti R; Rani R; Sevilimedu A; Kulkarni P; Yogeeswari P
    J Pharmacol Toxicol Methods; 2019; 95():56-65. PubMed ID: 30500431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral phenotypes and neurobiological mechanisms in the Shank1 mouse model for autism spectrum disorder: A translational perspective.
    Sungur AÖ; Schwarting RKW; Wöhr M
    Behav Brain Res; 2018 Oct; 352():46-61. PubMed ID: 28963042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats.
    Mirza R; Sharma B
    Brain Res Bull; 2019 Apr; 147():36-46. PubMed ID: 30769127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention or Amelioration of Autism-Like Symptoms in Animal Models: Will it Bring Us Closer to Treating Human ASD?
    Ornoy A; Weinstein-Fudim L; Ergaz Z
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30832249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxytocin Differentiated Effects According to the Administration Route in a Prenatal Valproic Acid-Induced Rat Model of Autism.
    Lefter R; Ciobica A; Antioch I; Ababei DC; Hritcu L; Luca AC
    Medicina (Kaunas); 2020 May; 56(6):. PubMed ID: 32485966
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanisms Underlying Microbial-Mediated Changes in Social Behavior in Mouse Models of Autism Spectrum Disorder.
    Sgritta M; Dooling SW; Buffington SA; Momin EN; Francis MB; Britton RA; Costa-Mattioli M
    Neuron; 2019 Jan; 101(2):246-259.e6. PubMed ID: 30522820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targets for Drug Therapy for Autism Spectrum Disorder: Challenges and Future Directions.
    Lacivita E; Perrone R; Margari L; Leopoldo M
    J Med Chem; 2017 Nov; 60(22):9114-9141. PubMed ID: 29039668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined the GABA-A and GABA-B receptor agonists attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of autism.
    Yang JQ; Yang CH; Yin BQ
    Behav Brain Res; 2021 Apr; 403():113094. PubMed ID: 33359845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxytocin and Animal Models for Autism Spectrum Disorder.
    Wagner S; Harony-Nicolas H
    Curr Top Behav Neurosci; 2018; 35():213-237. PubMed ID: 28864977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxytocin and Autism Spectrum Disorders.
    Yamasue H; Domes G
    Curr Top Behav Neurosci; 2018; 35():449-465. PubMed ID: 28766270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.